QA: Intelgenx Technologies Corp in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001098880_2020_Intelgenx_Technologies_Corp.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001098880, Intelgenx Technologies Corp

  xvar xval
0 AssetsCurrent 3,220,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 6,365,000
3 remainder_Assets 1,435,000
4 LiabilitiesCurrent 8,447,000
5 LiabilitiesNoncurrent 555,000
6 remainder_Liabilities 1,725,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 6,140,216
9 ResearchAndDevelopmentExpense 3,900,511
10 remainder_Expenses 718,106
11 remainder_Revenues 348,271
12 remainder_NetIncome -1,110,000
13 remainder_ComprehensiveNetIncome -197,972
  yvar yval
0 Assets 11,020,000
1 Liabilities 10,727,000
2 Expenses 10,758,833
3 Revenues 348,271
4 StockholdersEquity 293,000
5 NetIncome -11,520,562
6 ComprehensiveNetIncome -11,619,548
7 BaseVar 17,081,038
8 EconomicCapitalRatiobeforeLimitedLiability -1.01
9 EconomicCapitalRatio 1.30

Edgar->Model Mapping

Feature Distribution

Change over Time